GO
Loading...

Cramer: 12 things you missed in the market

(Click for video linked to a searchable transcript of this Mad Money segment)

Has Washington distracted you from these money making developments?

Over the past several days, the Washington debt debacle has been obscuring a lot," said Cramer. And once the cloud lifts, any or all of these catalyst could wield significant influence.

Aside from the debt dilemma, here are 12 developments Cramer found noteworthy over the past several days.

1. A new type of cholesterol drug from Regeneron and Sanofi reduced bad cholesterol in patients who otherwise can't take the current statin drugs. "It could easily mean $3 billion in sales, a genuine blockbuster that I think will be fast-tracked because of these results.

2. "We got some incredible European auto sales for September," Cramer said. The Mad Money host thinks developments bode well for Ford and General Motors. "Both should be able to report much better than expected numbers because of this turn as well as a better tone to Chinese sales."

3. Bank of America reported quarterly earnings and revenue that beat Wall Street's expectations on Tuesday, helped by favorable credit conditions, lower expenses and a rise in equity income. "When was the last time you heard something like that? I can see Bank of America returning to its greatness once again, with a big dividend and consistent growth."

Adam Jeffery | CNBC

4. PepsiCo reported higher quarterly earnings on Wednesday and said it was on track to meet its financial goals for the year, despite a sluggish economy. "They reported those strong results even though carbonated soda stalled in this country," Cramer said.

5. "Abbott delivered a terrific number and then a monster dividend boost from 14 cents to 22 cents," Cramer said.

6. Advance Auto Parts announced plans to buy General Parts International for just over $2 billion, creating the largest North American retailer of auto parts, as strong new car sales hit demand for repair and replacement.

7. "Two brokerage houses recommended Pioneer Natural Resources, the stock I've been telling you about lately because the company's sitting on a huge field in the Permian Basin that just might be the second largest oilfield on earth," Cramer said.

8. Deutsche Bank raised its price target for Cheniere Energy to $47.

9. Citigroup research said the FedEx buyback may signal turnaround progress.

10. SolarCity raised its guidance for next year significantly.

11. Shares of Veeva nearly doubled in their market debut on Wednesday, underscoring strong demand for cloud-based software makers with niche technologies and healthy revenue.

12. Twitter has chosen the New York Stock Exchange for its much buzzed-about IPO, according to an amended S-1 filing with the SEC. "That lit a fire under Facebook, Yelp and Linked-In," Cramer said.

--------------------------------------------------------
Read More from Mad Money with Jim Cramer
Chart patterns signal 'buy'
This stock deserves more respect
This theme transcends DC morass
--------------------------------------------------------

All told, Cramer thinks these developments bode well for the bulls. "There's tons of goods news in the market," he said. "If only Washington would get out of the way."

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
REGN
---
SAN
---
F
---
GM
---
ABT
---
PXD
---
LNG
---
FDX
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Cramer's New Book